Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 1, 2007, Pages 9-19

  Behbahani, Homira ^a   Walther Jallow, Lilian ^a   Klareskog, Elin ^a   Baum, Linda ^b   French, Audrey L ^c   Patterson, Bruce K ^d   Garcia, Patricia ^e   Spetz, Anna Lena ^a   Landay, Alan ^b   Andersson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemokine; Cytokine; Dendritic cells; Genital tract; Human papillomavirus; In situ imaging

Indexed keywords

ANTIGEN P24; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; INFLAMMATION; PRIORITY JOURNAL; TISSUE LEVEL; UTERINE CERVIX MUCOSA; VERRUCA VULGARIS; VIRUS TRANSMISSION; WART VIRUS;

ANTIGENS, CD1; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; DENDRITIC CELLS; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE SUBSETS; MACROPHAGE INFLAMMATORY PROTEIN-1; MUCOUS MEMBRANE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANTES; UTERINE CERVICAL DISEASES;

EID: 34247647969     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3180415da7     Document Type: Article

References (63)

1. Price MA, Zimba D, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis. 2003;30:516-522.
2. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349:1868-1873.
3. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis. 1997;175:57-62.
4. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS. 2003;17:455-480.
5. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother. 2001;12:133-150.
6. Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. [Erratum: N Engl J Med 1997;337(11):799.] N Engl J Med. 1997;336:1072-1078.
7. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005;5:783-792.
8. Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science. 1999;286:1353-1357.
9. Zhang ZQ, Wietgrefe SW, Li Q, et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci USA. 2004;101:5640-5645.
10. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA. 1993;269:2860-2864.
11. Devito C, Broliden K, Kaul R, et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol. 2000;165:5170-5176.
12. Devito C, Hinkula J, Kaul R, et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS. 2000;14:1917-1920.
13. Shine NR, Wang SC, Konopka K, et al. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein. Bioorg Chem. 2002;30:249-263.
14. Bogers WM, Bergmeier LA, Ma J, et al. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS. 2004;18:25-36.
15. Trabattoni D. Human α-defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr. 2004;15:455-463.
16. Mackewicz CE, Ortega H, Levy JA. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol. 1994;153:329-343.
17. Mackewicz CE, Yang LC, Lifson JD, et al. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet. 1994;344:1671-1673.
18. Schubert C. Restrictions on HIV. Nat Med. 2004;10:350.
19. Patterson BK, Behbahani H, Kabat WJ, et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from non-transmitting women. J Clin Invest. 2001;107:287-294.
20. Beyrer C, Artenstein AW, Rugpao S, et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis. 1999;179:59-67.
21. Kaul R, Plummer FA, Kimani J, et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol. 2000;164:1602-1611.
22. Lo Caputo S, Trabattoni D, Vichi F, et al. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS. 2003;17:531-539.
23. Hladik F, Lentz G, Delpit E, et al. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. J Immunol. 1999;163:2306-2313.
24. Patterson BK, Landay A, Andersson J, et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol. 1998;153:481-490.
25. Trapp S, Turville SG, Robbiani M. Slamming the door on unwanted guests: why preemptive strikes at the mucosa may be the best strategy against HIV. J Leukoc Biol. 2006;80:1076-1083.
26. Andersson J, Fehniger TE, Patterson BK, et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS. 1998;12:F123-F129.
27. Behbahani H, Landay A, Patterson BK, et al. Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:150-156.
28. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother. 2001;12:133-150.
29. Belyakov IM, Ahlers JD, Brandwein BY, et al. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest. 1998;102:2072-2081.
30. Belyakov IM, Wyatt LS, Ahlers JD, et al. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein. J Virol. 1998;72:8264-8272.
31. Musey L, Hu Y, Eckert L, et al. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med. 1997;185:293-303.
32. Olaitan A, Johnson MA, MacLean A, et al. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS. 1996;10:759-764.
33. Olaitan A, Johnson MA, Reid WM, et al. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin Exp Immunol. 1998;112:100-104.
34. Azar KK, Tani M, Yasuda H, et al. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol. 2004;35:1376-1384.
35. Palefsky J. Biology of HPV in HIV infection. Adv Dent Res. 2006;19:99-105.
36. Poljak M, Brencic A, Seme K, et al. Comparative evaluation of first- and second-generation Digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol. 1999;37:796-797.
37. Tjernlund A, Fleener Z, Behbahani H, et al. Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells. AIDS. 2003;17:1303-1310.
38. Bjork L, Fehniger TE, Andersson U, et al. Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. J Leukoc Biol. 1996;59:287-295.
39. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today. 1996;17:217-224.
40. Mackewicz CE, Barker E, Levy JA. Role of beta-chemokines in suppressing HIV replication. Science. 1996;274:1393-1395.
41. Servet C, Zitvogel L, Hosmalin A. Dendritic cells in innate immune responses against HIV. Curr Mol Med. 2002;2:739-756.
42. Kovacs A, Chan LS, Chen ZC, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J Acquir Immune Defic Syndr. 1999;22:124-131.
43. Gupta P, Collins KB, Ratner D, et al. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol. 2002;76:9868-9876.
44. Chun TW, Engel D, Mizell SB, et al. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. [Erratum: J Exp Med 1998;188(3):614.] J Exp Med. 1998;188:83-91.
45. Connor RI, Mohri H, Cao Y, et al. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol. 1993;67:1772-1777.
46. de Wolf F, Spijkerman I, Schellekens PT, et al. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS. 1997;11:1799-1806.
47. Chun TW, Engel D, Mizell SB, et al. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med. 1998;188:83-91.
48. Taguchi M, Sampath D, Koga T, et al. Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med. 1998;187:1927-1940.
49. Iversen AK, Attermann J, Gerstoft J, et al. Longitudinal and cross-sectional studies of HIV-RNA and DNA loads in blood and the female genital tract. Eur J Gynecol Reprod Biol. 2004;1:227-235.
50. Iversen AK, Fugger L, Eugen-Olsen J, et al. Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion. J Infect Dis. 1998;178:1334-1342.
51. Lederman MM, Veazey RS, Offord R, et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science. 2004;306:485-487.
52. Walker CM, Moody DJ, Stites DP, et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986;234:1563-1566.
53. Schneider A, Shah K. The role of vitamins in the etiology of cervical neoplasia: an epidemiological review. Arch Gynecol Obstet. 1989;246:1-13.
54. Nicol AF, Nuovo GJ, Wang Y, et al. In situ detection of SOCS and cytokine expression in the uterine cervix from HIV/HPV coinfected women. Exp Mol Pathol. 2006;81:42-47.
55. Kobayashi A, Greenblatt RM, Anastos K, et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004;64:6766-6774.
56. Lee BN, Follen M, Shen DY, et al. Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions. Clin Diagn Lab Immunol. 2004;11:239-244.
57. El-Sherif AM, Seth R, Tighe PJ, et al. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol. 2001;195:179-185.
58. Nicol AF, Fernandes AT, Grinsztejn B, et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol. 2005;14:39-47.
59. Scott M, Stites DP, Moscicki AB. Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol. 1999;6:751-755.
60. Labeit D, Labeit S, Berger M, et al. Interferon-alpha kontrolliert die HPV-Infektion im Zervixepithel [in German]. Zentralbl Gynakol. 1995;117:566-577.
61. McDermott MR, Brais LJ, Evelegh MJ. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J Gen Virol. 1990;71:1497-1504.
62. McDermott MR, Goldsmith CH, Rosenthal KL, et al. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J Infect Dis. 1989;159:460-466.
63. Parr MB, Kepple L, McDermott MR, et al. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest. 1994;70:369-380.